$TRUP

WEINRAUCH STEVE sold $147K of TRUP

WEINRAUCH STEVE (EVP, North Am & Vet Strategy) sold 6,674 shares of TRUPANION, INC. (TRUP) at $22.00 ($0.15M total) on 2026-06-05.

Original reporting
SEC EDGAR · WEINRAUCH STEVE
Published Jun 9, 2026, 11:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 11:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
high confidence
Mentioned
$TRUP
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The newest fact is the officer’s open-market sale amount, which may slightly affect sentiment but does not, by itself, change the company’s operating outlook.

02

Market read

Traders may note the insider sale as a minor sentiment datapoint, but there is no accompanying fundamental news in the text.

03

What to watch

The article provides only one sale transaction size and price; it does not include prior insider activity trends, option exercises, or broader ownership changes that would contextualize signal strength.

Relevance 4/10Novelty 2/10Timing: Filed 2026-06-09; sale executed 2026-06-05.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for TRUPANION, Inc.

Company-level read

Ticker impact

$TRUPNeutralHigh confidence
Context

SEC Form 4 shows TRUPANION EVP Steve Weinrauch sold 6,674 shares (~$146,828) on 2026-06-05 via open-market sale.

Expected impact

Likely minimal near-term price impact; any effect would be sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing is a disclosed open-market sale by an officer, with no 10b5-1 plan and no accompanying operational/regulatory news in the text.

Market effects

No sector-level read-through provided; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; without a 10b5-1 plan, the sale still may not imply negative fundamentals.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction is disclosed on SEC Form 4.

  • WEINRAUCH STEVE

    EVP, North Am & Vet Strategy; reported open-market sale of TRUP shares.

Related articles

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991q22026.htm EX-99.1 Document Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced fin